We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Solving POC Test Communication Challenges to EMRs

By LabMedica International staff writers
Posted on 02 Dec 2009
Print article
According to a leading healthcare market research publisher, a key question users of glucose monitors and other point-of-care (POC) tests may ask is "does the POC test talk to the user's electronic medical record (EMR).” As wireless communication becomes standard in hospitals, it is incumbent on the US$13 billion worldwide market for POC test systems to participate fully in this phenomenon.

Connectivity is a high priority issue in order for hospital POC testing and critical care device markets to expand, according to the findings of a recent market report from healthcare market research publisher Kalorama Information (New York, NY, USA). "On-the-spot access to patient information and care guidelines is part of the healthcare quality imperative of the 21st century,” noted Shara Rosen, Kalorama Information's diagnostics analyst. "Cost reduction pressures and the need for shortened in-patient stays are promoting the use of wireless communication in and out of hospitals.”

While the worldwide medical community is racing to embrace EMR and telemedicine, most POC test devices currently have limited connectivity capabilities and cannot participate. At this time, all major lab-based instruments interface automatically to a laboratory information system (LIS) or hospital information system (HIS) system. However, many glucose monitors in hospital wards do not have this connectivity capability and so they do not become part of a patient's EMR. The same applies to almost all pregnancy and urinalysis tests performed in the hospital but outside the laboratory.

Within today's hospital environment of limited resources, cost pressures, decentralized patient information, large investment in new technologies and increased regulatory scrutiny, healthcare is more challenging than ever before. POC testing is poised to provide a solution to some of these economic pressures. However, without first-class connectivity solutions, POC testing cannot provide the expected benefits in improved patient care that will lead to cost reductions. "Any manufacturers who want to make their POC products incredibly valuable should make sure they can link up with major EMR systems,” said Ms. Rosen.

Beyond the connectivity issue, the next frontier is continuous monitoring of patients in acute care and in selected treatment areas such as dialysis, intensive care, and the operating room (OR). Moreover, as the number of POC tests continues to grow, potential users will not want to learn to use a large number of devices. Therefore, considerable research has been ongoing for about a decade on a multipurpose POC platform that can run chemistries and immunoassays.

Kalorama Information supplies independent market research in the life sciences, as well as a full range of custom research services.

Related Links:
Kalorama Information

Gold Member
Rickettsia Conorii Assay
RICKETTSIA CONORII ELISA
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Clostridium Difficile Test
VIDITEST C. Difficile Toxin A+B (Card) Rapid Test
New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The MCED test can screen for up to 42 solid tumors and five hematological tumors (Photo courtesy of 123RF)

Non-Invasive Test Detects Up To 42 Solid Tumors and Five Blood Cancers in Blood and Urine Samples

Cancer is now responsible for nearly 1 in 6 deaths worldwide. Each year, over 14 million people are diagnosed with cancer, and this number is expected to surpass 21 million by 2030. A major issue is that... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Pathology

view channel
Image: The PAXgene Urine Liquid Biopsy Set is the first standardized preanalytical workflow that stabilizes cell-free DNA in urine for subsequent analysis (Photo courtesy of PreAnalytiX)

Liquid Biopsy Solution Enables Non-Invasive Sample Collection and Direct Cell-Free DNA Stabilization from Urine

Urine cell-free DNA (cfDNA) presents significant potential for research and future clinical applications. It facilitates the measurement and analysis of cfDNA fragments, detection of genetic alterations,... Read more

Industry

view channel
Image: International expert meeting for trends and innovations in laboratory medicine - the MEDICA LABMED FORUM at MEDICA (Photo courtesy of Constanze Tillmann/Messe Düsseldorf)

MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine

At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.